Key details
Sponsor
Fundación Española de Hematología y Hemoterapía
Enrollment target
~210 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 99 Years
Last updated February 2026